Title
Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD
A Randomized Clinical Trial Comparing Computer-assisted Cognitive Rehabilitation (CACR), Psycho-stimulants, and Placebo CACR in the Treatment of Attention Deficit/ Hyperactivity Disorder
Phase
Phase 3Lead Sponsor
Allameh Tabatabai UniversityStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
Attention Deficit Disorder With HyperactivityIntervention/Treatment
methylphenidate ...Study Participants
34Current research aimed to compare the efficacy of computer-assisted cognitive rehabilitation (CACR), stimulant drugs and Placebo CACR on executive functions and clinical symptoms of children with attention deficit/hyperactivity disorder (ADHD).
The investigators administered a randomized controlled trial (RCT) through random assignment of ADHD subjects in to three different groups to compare the effects of CACR, immediate-release methylphenidate, and a Placebo CACR (i.e. some computerized tasks assumed not having any therapeutic effects) on the functioning of children with ADHD.
- Computerized cognitive rehabilitation: 20 ninety-minute sessions of computerized cognitive rehabilitation.
-drug therapy: 2 or 3 doses of 10 mg tablets of Immediate-release Methylphenidate (Ritalin) per day for 2 months.
PCACR: 20 ninety-minute sessions of Placebo computerized cognitive training.
-Computer-assisted cognitive rehabilitation (CACR): 20 Ninety-minute sessions of CACR.
-PCACR group simultaneously received 20 Ninety-minute sessions of Placebo CACR.
Inclusion Criteria: ADHD diagnosis age between 7 and 12 IQ > 85 Exclusion Criteria: sever co-morbid disorder seizure IQ < 85 disability sever medical condition